Effects of two types of fish oil supplements on serum lipids and plasma phospholipid fatty acids in coronary artery disease
- 1 November 1990
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 66 (17), 1171-1175
- https://doi.org/10.1016/0002-9149(90)91093-l
Abstract
No abstract availableThis publication has 30 references indexed in Scilit:
- RANDOMISED TRIAL OF FISH OIL FOR PREVENTION OF RESTENOSIS AFTER CORONARY ANGIOPLASTYThe Lancet, 1989
- Heterogeneity of low density lipoprotein responses to fish-oil supplementation in hypertriglyceridemic subjects.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1989
- The effects of ω3 and ω6 fatty acid-enriched diets on plasma lipoproteins and apoproteins in familial combined hyperlipidemiaMetabolism, 1988
- Reduction in the Rate of Early Restenosis after Coronary Angioplasty by a Diet Supplemented with n–3 Fatty AcidsNew England Journal of Medicine, 1988
- Effects of a Low Saturated Fat, Low Cholesterol Fish Oil Supplement in Hypertriglyceridemic PatientsAnnals of Internal Medicine, 1988
- Prophylaxis of Atherosclerosis with Marine Omega-3 Fatty AcidsAnnals of Internal Medicine, 1987
- Paradoxical elevation of LDL apoprotein B levels in hypertriglyceridaemic patients and normal subjects ingesting fish oilAtherosclerosis, 1986
- Reduction of Plasma Lipids, Lipoproteins, and Apoproteins by Dietary Fish Oils in Patients with HypertriglyceridemiaNew England Journal of Medicine, 1985
- Dietary omega-3 fatty acids prevent carbohydrate-induced hypertriglyceridemiaMetabolism, 1984
- Inhibition of low density lipoprotein synthesis by dietary omega-3 fatty acids in humans.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1984